Targeting synaptic dysfunction in Alzheimer's disease therapy

Keyphrases

• Alzheimer's Disease 100%
• Synaptic Dysfunction 100%
• Alzheimer's Disease Treatment 100%
• Transgenic Mouse Model 66%
• Alzheimer's Disease Model 66%
• Disease Progression 33%
• Non-transgenic 33%
• Transgenic Mice 33%
• Molecular Pathogenesis 33%
• Therapeutic Approaches 33%
• Synaptic Remodeling 33%
• Temporal Evolution 33%
• Transgenic Technology 33%
• Disease-modifying Therapy 33%
• Cognitive Decline 33%
• Electrophysiological Study 33%
• Human Trials 33%
• Long-term Potentiation 33%
• Pharmacological Strategies 33%
• Synapse Loss 33%
• Target Validation 33%
• Experimental Tools 33%
• Phenotypic Characterization 33%
• Lines of Evidence 33%
• Cellular Models 33%
• Intrinsic Limits 33%
• Slowing down 33%
• Exogenous Application 33%
• Pharmacological Intervention 33%
• Hippocampal Plasticity 33%
• Genetic Pathogenesis 33%
• Hippocampal Synaptic Function 33%

Biochemistry, Genetics and Molecular Biology

• Transgenic Organism 100%
• Mouse Model 50%
• Genetics 50%
• Clinical Trial 50%
• Transgenic Mouse 50%
• Transgenics 50%
• Animal Model 50%
• Preclinical Study 50%
• Synapse 50%
• Synaptic Transmission 50%
• Translating (Language) 50%
• Long Term Potentiation 50%

Neuroscience

• Alzheimer's Disease 100%
• Synapse 16%
• Behavior (Neuroscience) 16%
• Long-Term Potentiation 16%
• Synaptic Transmission 16%